98 Results

People

  1. Clarkson
    Clarkson
  2. Sawyers
    Sawyers
  3. Mauro
    Mauro
  4. Scheinberg
    Scheinberg
  5. Wisniewski
    Wisniewski
  6. Strife
    Strife
  7. Berman
    Berman
  8. Ladanyi
    Ladanyi
  9. Levine
    Levine
  10. Pinilla
    Pinilla

Groups

  1. Department of Medicine (67)
  2. Hematologic Malignancies, Division of (63)
  3. Center for Hematologic Malignancies (51)
  4. GSK Faculty (45)
  5. Adult Leukemia (34)
  6. Sloan Kettering Institute Faculty (34)
  7. Tow Center for Developmental Oncology (TCDO) (32)
  8. Molecular Pharmacology and Chemistry Program Faculty (30)
  9. Human Oncology and Pathogenesis Program (22)
  10. Executive Committee, Center for Hematologic Malignancies (20)
  1. "bcr abl protein"
Formats
  1. Journal Article (93)
  2. Review (2)
  3. Conference Paper (1)
  4. Correspondence (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (67)
  2. Hematologic Malignancies, Division of (63)
  3. Center for Hematologic Malignancies (51)
  4. GSK Faculty (45)
  5. Adult Leukemia (34)
  6. Sloan Kettering Institute Faculty (34)

More Groups

People
  1. Bayard Clarkson (15)
  2. Charles Sawyers (12)
  3. David Scheinberg (10)
  4. Michael Mauro (10)
  5. Darren Veach (9)
  6. David Wisniewski (7)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (1)
  4. 2022 (1)
  5. 2020 (1)
  6. 2018 (1)

More Years

Publications
  1. Blood (10)
  2. Leukemia (10)
  3. Journal of the National Comprehensive Cancer Network (5)
  4. Haematologica (3)
  5. Proceedings of the National Academy of Sciences of the United States of America (3)
  6. American Journal of Hematology (2)

More Publications

Publishers
  1. Nature Publishing Group (15)
  2. American Society of Hematology (10)
  3. American Association for Cancer Research (7)
  4. Elsevier Inc. (7)
  5. Harborside Press (5)
  6. Wiley Blackwell (5)

More Publishers

Results (98)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results: CHRONIC MYELOID LEUKEMIA
    Journal Article

    Hochhaus, A.; Kim, D. W.; Cortes, J. E.; Sasaki, K.; Mauro, M. J.; Hughes, T. P.; Breccia, M.; Talpaz, M.; Minami, H.; Goh, Y. T.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Impact of recent translational and therapeutic developments on clinical course of BCR::ABL1-positive and -negative myeloproliferative neoplasms
    Review

    Mughal, T. I.; Mascarenhas, J.; Rampal, R. K.; Bose, P.; Lion, T.; Ajufo, H.; Yacoub, A.; Meshinchi, S.; Masarova, L.; Mesa, R.; more...
    Hematological Oncology (2025)

    Fulltext@MSK | Save
  • Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results
    Journal Article

    Cortes, J. E.; Sasaki, K.; Kim, D. W.; Hughes, T. P.; Etienne, G.; Mauro, M. J.; Hochhaus, A.; Lang, F.; Heinrich, M. C.; Breccia, M.; more...
    Leukemia (2024)

    Fulltext@MSK | Save
  • Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: Cell-of-origin, biology, and clinical implications
    Journal Article

    Aypar, U.; Dilip, D.; Gadde, R.; Londono, D. M.; Liu, Y.; Gao, Q.; Geyer, M. B.; Derkach, A.; Zhang, Y.; Glass, J. L.; more...
    Histopathology (2024)

    Fulltext@MSK | Save
  • BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis
    Correspondence

    Kockerols, C.; Valk, P. J. M.; Dulucq, S.; Nicolini, F. E.; Mahon, F. X.; Atallah, E.; Mauro, M. J.; Radich, J. P.; Bernardi, S.; Russo, D.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
    Journal Article

    Jabbour, E.; Apperley, J.; Cortes, J.; Rea, D.; Deininger, M.; Abruzzese, E.; Chuah, C.; DeAngelo, D. J.; Hochhaus, A.; Lipton, J. H.; more...
    Leukemia (2024)

    Fulltext@MSK | Save
  • Chronic myeloid leukemia, version 2.2024, NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    Shah, N. P.; Bhatia, R.; Altman, J. K.; Amaya, M.; Begna, K. H.; Berman, E.; Chan, O.; Clements, J.; Collins, R. H. Jr; Curtin, P. T.; more...
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results
    Journal Article

    Mauro, M. J.; Hughes, T. P.; Kim, D. W.; Rea, D.; Cortes, J. E.; Hochhaus, A.; Sasaki, K.; Breccia, M.; Talpaz, M.; Ottmann, O.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia
    Journal Article

    Kantarjian, H. M.; Jabbour, E.; Deininger, M.; Abruzzese, E.; Apperley, J.; Cortes, J.; Chuah, C.; DeAngelo, D. J.; DiPersio, J.; Hochhaus, A.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • The clinical management of clonal hematopoiesis: Creation of a clonal hematopoiesis clinic
    Review

    Bolton, K. L.; Zehir, A.; Ptashkin, R. N.; Patel, M.; Gupta, D.; Sidlow, R.; Papaemmanuil, E.; Berger, M. F.; Levine, R. L.
    Hematology/Oncology Clinics of North America (2020)

    Fulltext@MSK | Save